COSCIENS Biopharma, Inc. (CSCI.TO)
1.96
+0.06
(+3.16%)
CAD |
TSX |
Mar 13, 12:41
COSCIENS Biopharma Total Liabilities (Quarterly) : 26.13M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arch Biopartners, Inc. | 3.624M |
| Biocure Technology, Inc. | 0.4131M |
| Microbix Biosystems, Inc. | 9.983M |
| Theratechnologies, Inc. | 108.88M |
| Aptose Biosciences, Inc. | 35.89M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.20M |
| Shareholders Equity (Quarterly) | 7.068M |
| Debt to Equity Ratio | 0.4274 |
| Current Ratio | 3.474 |
| Net Debt Paydown Yield | -1.23% |